CS402291A3 - Derivatives of 3,5 di-substituted pyrocatechol and pharmaceuticalcompositions based thereon - Google Patents

Derivatives of 3,5 di-substituted pyrocatechol and pharmaceuticalcompositions based thereon

Info

Publication number
CS402291A3
CS402291A3 CS914022A CS402291A CS402291A3 CS 402291 A3 CS402291 A3 CS 402291A3 CS 914022 A CS914022 A CS 914022A CS 402291 A CS402291 A CS 402291A CS 402291 A3 CS402291 A3 CS 402291A3
Authority
CS
Czechoslovakia
Prior art keywords
pharmaceuticalcompositions
derivatives
pyrocatechol
substituted
substituted pyrocatechol
Prior art date
Application number
CS914022A
Other languages
Czech (cs)
Inventor
Karl Bernauer
Janos Borgulya
Hans Bruderer
Prada Mose Da
Gerhard Zurcher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS402291A3 publication Critical patent/CS402291A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
    • C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
CS914022A 1986-03-11 1991-12-23 Derivatives of 3,5 di-substituted pyrocatechol and pharmaceuticalcompositions based thereon CS402291A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH98086 1986-03-11
CH6287 1987-01-09

Publications (1)

Publication Number Publication Date
CS402291A3 true CS402291A3 (en) 1992-12-16

Family

ID=25683401

Family Applications (1)

Application Number Title Priority Date Filing Date
CS914022A CS402291A3 (en) 1986-03-11 1991-12-23 Derivatives of 3,5 di-substituted pyrocatechol and pharmaceuticalcompositions based thereon

Country Status (22)

Country Link
EP (1) EP0237929B1 (en)
JP (1) JPH0742254B2 (en)
AR (1) AR245097A1 (en)
AT (1) ATE90072T1 (en)
AU (1) AU603788B2 (en)
CA (1) CA1302418C (en)
CS (1) CS402291A3 (en)
DE (1) DE3786026D1 (en)
DK (1) DK175069B1 (en)
ES (1) ES2056792T3 (en)
FI (1) FI91396C (en)
HK (1) HK165896A (en)
HU (1) HU201900B (en)
IE (1) IE61316B1 (en)
IL (1) IL81791A (en)
LU (1) LU90219I2 (en)
LV (1) LV5742B4 (en)
MC (1) MC1807A1 (en)
NL (1) NL970041I1 (en)
NO (2) NO165959C (en)
NZ (1) NZ219496A (en)
PT (1) PT84449B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
FI864875A0 (en) * 1986-11-28 1986-11-28 Orion Yhtymae Oy NYA FARMAKOLOGISKT AKTIVA FOERENINGAR, DESSA INNEHAOLLANDE KOMPOSITIONER SAMT FOERFARANDE OCH MELLANPRODUKTER FOER ANVAENDNING VID FRAMSTAELLNING AV DESSA.
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
GB9113431D0 (en) * 1991-06-20 1991-08-07 Orion Yhytma Oy Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde
GB9419274D0 (en) * 1994-09-23 1994-11-09 Orion Yhtymae Oy New method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde
GB9626472D0 (en) 1996-12-20 1997-02-05 Aperia Anita C New use of comt inhibitors
ID19540A (en) * 1997-01-22 1998-07-23 Hoffmann La Roche METHOD OF MAKING BENZOFENON DECREASES
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB2344819A (en) * 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
DE19960105A1 (en) * 1999-12-14 2001-06-21 Haarmann & Reimer Gmbh Catechol oximes and their use in cosmetic and dermatological preparations
FI20000635A0 (en) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj Use of COMT inhibitors as an analgesic
WO2001087857A1 (en) * 2000-05-16 2001-11-22 Nippon Soda Co., Ltd. Phenyloxazole compounds and fungicides for agricultural and horticultural use
GB2363792A (en) * 2000-06-21 2002-01-09 Portela & Ca Sa Nitrocatechols
GB0015228D0 (en) * 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders
FI20012242A0 (en) * 2001-11-19 2001-11-19 Orion Corp New pharmaceutical compounds
US8158149B2 (en) 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US20060105036A1 (en) 2003-05-12 2006-05-18 Stephen Peroutka Threo-dops controlled release formulation
CA2563704A1 (en) 2004-05-04 2005-11-24 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
DE102004023332A1 (en) * 2004-05-12 2006-01-19 Bayer Cropscience Gmbh Quinoxaline-2-one derivatives, crop protection agents containing them, and processes for their preparation and their use
WO2006051154A1 (en) 2004-11-10 2006-05-18 Orion Corporation Treatment of restless legs syndrome
BRPI0613859B8 (en) * 2005-07-26 2021-05-25 Bial Portela & Ca Sa comt inhibitors, their uses, and pharmaceutical composition
EP1845097A1 (en) * 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
ES2383768T3 (en) 2006-06-28 2012-06-26 Chelsea Therapeutics Inc. Pharmaceutical compositions comprising droxidopa
CA2670134A1 (en) 2006-11-21 2008-08-28 Beth Israel Deaconess Medical Center Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
CA2678391C (en) 2007-01-31 2017-01-17 David Alexander Learmonth Dosage regimen for comt inhibitors
MX2009009624A (en) 2007-03-09 2009-12-11 Chelsea Therapeutics Inc Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia.
JP2010526820A (en) 2007-05-07 2010-08-05 チェルシー・セラピューティクス，インコーポレイテッド Droxidopa and pharmaceutical composition thereof for treating mood disorder, sleep disorder, or attention deficit disorder
JP2009126784A (en) * 2007-11-19 2009-06-11 Mitsubishi Gas Chem Co Inc Method for producing 2-iodo-3,4-dimethoxybenzonitrile
RU2459812C2 (en) 2007-12-25 2012-08-27 Киссеи Фармасьютикал Ко., Лтд. New catechin derivative, pharmaceutical composition containing catechin derivative, using catechin derivative and using pharmaceutical composition
CL2009000628A1 (en) 2008-03-17 2010-04-09 Bial Portela & Companhia S A Crystalline form of 5- [3- (2,5-dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl) - [1,2,4] oxadiazol-5-yl] -3-nitrobenzene- 1,2-diol, a pharmaceutical composition that comprises it, a process to obtain it and its use to treat mood disorders, Parkinson's disease and Parkinsonian disorders, gastrointestinal disorders, among others.
US8258162B2 (en) 2008-07-04 2012-09-04 Kissei Pharmaceutical Co., Ltd. Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
KR20120027197A (en) 2009-04-01 2012-03-21 바이알 - 포르텔라 앤드 씨에이 에스에이 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
JP5707063B2 (en) * 2009-06-18 2015-04-22 キッセイ薬品工業株式会社 Novel catechol derivatives, pharmaceutical compositions containing them, and uses thereof
JP5529639B2 (en) * 2009-06-18 2014-06-25 キッセイ薬品工業株式会社 Novel catechol-O-methyltransferase inhibitor
AU2011222856B2 (en) 2010-03-04 2015-10-15 Orion Corporation Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
JP5880913B2 (en) 2011-05-17 2016-03-09 三郎 佐古田 Treatment for trunk symptoms (postural reflex abnormalities) in Parkinson's disease
PT3604299T (en) 2011-12-13 2023-10-31 Bial Portela & Ca Sa Chemical compound useful as intermediate for preparing a catechol-0-methyl transferase inhibitor
CA2863585A1 (en) 2012-01-31 2013-08-08 Lundbeck Na Ltd. Improving postural stability administering droxidopa
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
TWI638802B (en) * 2012-05-24 2018-10-21 芬蘭商奧利安公司 Catechol o-methyltransferase activity inhibiting compounds
WO2014147464A2 (en) * 2013-03-20 2014-09-25 Ra Chem Pharma Limited Novel process for the preparation of tolcapone
JP2018500300A (en) 2014-11-28 2018-01-11 ノヴィファーマ，エス．アー． Medicines for delaying Parkinson's disease
AU2016377785B2 (en) 2015-12-24 2021-07-01 The Regents Of The University Of California CFTR regulators and methods of use thereof
JP2020158391A (en) * 2017-06-13 2020-10-01 株式会社富士薬品 Novel nitrocatechol derivative
US11872236B2 (en) 2018-04-05 2024-01-16 Calasia Pharmaceuticals, Inc. Pharmacological agents for treating ocular diseases
CN114560771B (en) * 2022-03-07 2023-10-27 中北大学 Method for photocatalytic selective nitration of bromophenol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128542A (en) * 1978-03-27 1979-10-05 Ube Ind Ltd Preparation of 3-cyanocatechol derivative
GB2038819B (en) * 1978-12-21 1983-02-16 Secr Defence Initiatory explosives comprising a lead salt of 3,5-dinitro-catechol
EP0142283B1 (en) * 1983-10-25 1991-01-30 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
DE3406329A1 (en) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt PYRIDONE
CA1339860C (en) * 1985-06-17 1998-05-12 Tsunehiko Soga Derivatives of penem

Also Published As

Publication number Publication date
NZ219496A (en) 1990-12-21
ES2056792T3 (en) 1994-10-16
DK82087D0 (en) 1987-02-18
ATE90072T1 (en) 1993-06-15
EP0237929A1 (en) 1987-09-23
JPH0742254B2 (en) 1995-05-10
DK82087A (en) 1987-09-12
IE870609L (en) 1987-09-11
CA1302418C (en) 1992-06-02
DE3786026D1 (en) 1993-07-08
IL81791A0 (en) 1987-10-20
AU6976487A (en) 1987-09-17
LU90219I2 (en) 1998-05-28
FI91396C (en) 1994-06-27
DK175069B1 (en) 2004-05-24
MC1807A1 (en) 1987-12-22
NO165959C (en) 1991-05-08
HU201900B (en) 1991-01-28
IE61316B1 (en) 1994-11-02
LV5742B4 (en) 1996-12-20
NO870984L (en) 1987-09-14
EP0237929B1 (en) 1993-06-02
NO870984D0 (en) 1987-03-10
NL970041I1 (en) 1998-02-02
HK165896A (en) 1996-09-13
FI91396B (en) 1994-03-15
PT84449A (en) 1987-04-01
NO165959B (en) 1991-01-28
AU603788B2 (en) 1990-11-29
AR245097A1 (en) 1993-12-30
IL81791A (en) 1992-12-01
JPS62240649A (en) 1987-10-21
PT84449B (en) 1989-10-04
FI871041A (en) 1987-09-12
LV5742A4 (en) 1996-10-20
NO1998006I1 (en) 1998-01-28
HUT43804A (en) 1987-12-28
FI871041A0 (en) 1987-03-10

Similar Documents

Publication Publication Date Title
CS402291A3 (en) Derivatives of 3,5 di-substituted pyrocatechol and pharmaceuticalcompositions based thereon
YU198087A (en) Process for obtaining nor-statine and nor-cyclostatine
PT82226A (en) Process for the preparation of 3-aryluraciles and pesticeides therewith
GB8629223D0 (en) Replication of carriers
GB2193692B (en) Single and or double infant carriage
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
EP0237967A3 (en) Il-1b derivatives and drugs
EP0260121A3 (en) Inosose derivatives, production and use thereof
GR3003110T3 (en) Inosose derivatives and production thereof
NZ218856A (en) Aminoglycosides of 3,21-dihydroxy-14,21-epoxy-24-nor-cholanic acid and derivatives
EP0252357A3 (en) Process for the preparation of (4-hydroxyphenyl)-4-hydroxy-benzoate, and its use
ZA879235B (en) Peridone derivatives,and their preparation and use
GB2159817B (en) Preparation of amidohydroxycephams, novel aminoacyloxycephams and derivatives thereof
DE3662970D1 (en) Improved blood-purifying membrane and process for preparation thereof
CS264686A3 (en) Aminoketone derivatives and process for preparing thereof
YU72387A (en) Process for obtaining derivatives of benzimidazole-2-sulphonamide and imidazopyridin-2-sulphonamide
GB2190918B (en) Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom
DE3760806D1 (en) Monohalogenotrifluorooxetane and its preparation
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
EP0263309A3 (en) Bromofluoroethylhypofluorite and process for its preparation
EP0238357A3 (en) 1,2,4-triazinone derivatives, their preparation and use
SG42491G (en) Novel derivatives based upon pyridomenadione adducts and uses thereof
GB2194235B (en) Dichlorotrifluoromethyltoluenes and preparation thereof
IL83370A0 (en) Preparation of 3,4-diamino-5-benzylpyrimidines
GB2196961B (en) Preparation of polyfluoroenolates